Experiments with MIN6 insulinoma beta cell line determined that miR-29 targets a member of the BCL2 family, an antiapoptotic protein, the MCL1 (myeloid cell leukemia 1) (MCL-1) gene. Here, MCL1 is linked to pancreatic insulinoma.